![Gordon Treadway](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gordon Treadway
Presidente presso Culture Partners
Posizioni attive di Gordon Treadway
Società | Posizione | Inizio | Fine |
---|---|---|---|
Culture Partners
![]() Culture Partners Miscellaneous Commercial ServicesCommercial Services Culture Partners engages in the provision of accountability training and consulting services. Its practice areas are accountability, accelerating culture change, employee engagement, execution and implementation, executive team alignment, information technology culture, and leadership development. The company was founded by Roger Connors and Tom Smith in 1989 and is headquartered in Temecula, CA. | Presidente | 01/01/2013 | - |
Amministratore Delegato | 01/01/2016 | - |
Storia della carriera di Gordon Treadway
Precedenti posizioni note di Gordon Treadway
Società | Posizione | Inizio | Fine |
---|---|---|---|
Tercica, Inc.
![]() Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Vendite & Marketing | 01/01/2007 | 03/02/2014 |
Formazione di Gordon Treadway
Brigham Young University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Posizioni
Sales & Marketing | 1 |
Undergraduate Degree | 1 |
Chief Executive Officer | 1 |
Settori
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Tercica, Inc.
![]() Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Culture Partners
![]() Culture Partners Miscellaneous Commercial ServicesCommercial Services Culture Partners engages in the provision of accountability training and consulting services. Its practice areas are accountability, accelerating culture change, employee engagement, execution and implementation, executive team alignment, information technology culture, and leadership development. The company was founded by Roger Connors and Tom Smith in 1989 and is headquartered in Temecula, CA. | Commercial Services |
- Borsa valori
- Insiders
- Gordon Treadway
- Esperienza